T. Gonda et al. / Tetrahedron: Asymmetry xxx (2016) xxx–xxx
5
4.3.1. (1R,2R,4R)-2,2,2-Trichloro-N-[1-(1,2-dihydroxy-4-methyl-
cyclohexyl)-1-methyl-ethyl]-acetamide 5a
solved in H2O and extracted with CH2Cl2 (3 ꢁ 30 mL). The com-
bined organic layer was dried (Na2SO4), filtered and evaporated
to dryness. The obtained crude product was purified by column
chromatography on silica gel (toluene/ethanol = 4/1).
Isolated compound: 1.0 g (39%); white crystals; mp: 155–
157 °C; ½a 2D0
ꢂ
= +27 (c 0.250, MeOH). 1H NMR (400 MHz, CDCl3) d
0.94 (3H, d, J = 6.0 Hz), 1.53 (3H, s), 1.54 (3H, s), 1.20–1.56 (5H,
m), 1.69–1.81 (2H, m), 2.00 (1H, d, J = 6.9 Hz), 2.84 (1H, s), 3.83–
3.92 (1H, m), 8.11 (1H, br s). 13C NMR (100 MHz, CDCl3) d 21.6,
21.8, 22.8, 29.4, 30.9, 31.1, 40.7, 63.3, 72.2, 76.2, 93.9, 161.7. Anal.
Calcd for C12H20Cl3NO3: C, 43.33; H, 6.06; Cl, 31.97; N, 4.21. Found:
C, 43.47; H, 6.11; Cl, 31.80; N, 4.07.
4.5.1. (1R,2R,4R)-1-(1-Benzylamino-1-methylethyl)-4-methyl-
cyclohexane-1,2-diol 7a
Isolated compound: 0.40 g (54%); white crystals; mp: 125–
128 °C; ½a 2D0
ꢂ
= +27 (c 0.250, MeOH). 1H NMR (400 MHz, CDCl3) d
0.92 (3H, d, J = 6.3 Hz), 1.21 (3H, s), 1.27 (3H, s), 1.18–1.29 (3H,
m), 1.34–1.48 (2H, m), 1.67–1.77 (2H, m), 3.76 (2H, q, J = 12.3,
12.3 Hz), 3.98 (1H, dd, J = 4.7, 11.4 Hz), 7.21–7.35 (5H, m). 13C
NMR (100 MHz, CDCl3) d 19.9, 21.8, 22.0, 29.8, 30.3, 30.6, 39.0,
46.3, 61.3, 72.4, 75.8, 127.5, 128.6, 128.8, 139.4. Anal. Calcd for
4.3.2. (1S,2S,4R)-2,2,2-Trichloro-N-[1-(1,2-dihydroxy-4-methyl-
cyclohexyl)-1-methyl-ethyl]-acetamide 5b
Isolated compound: 1.0 g (39%); white crystals; mp: 172–
174 °C. ½a 2D0
ꢂ
= ꢀ18 (c 0.250, MeOH). 1H NMR (400 MHz, CDCl3) d
C17H27NO2: C, 73.61; H, 9.81; N, 5.05. Found: C, 73.71; H, 10.00;
N, 5.09.
0.98 (3H, d, J = 7.3 Hz), 1.28–1.36 (1H, m), 1.54 (3H, s), 1.55 (3H,
s), 1.57–1.64 (3H, m), 1.79–1.91 (2H, m), 1.98 (1H, d, J = 7.1 Hz),
2.02–2.12 (1H, m), 2.88 (1H, s), 4.01–4.14 (1H, m), 8.10 (1H, br
s). 13C NMR (100 MHz, CDCl3) d 17.7, 21.7, 22.9, 25.9, 26.2, 27.3,
37.8, 63.4, 68.1, 76.8, 161.8. Anal. Calcd for C12H20Cl3NO3: C,
43.33; H, 6.06; Cl, 31.97; N, 4.21. Found: C, 43.51; H, 6.01; Cl,
32.03; N, 4.15.
4.5.2. (1S,2S,4R)-1-(1-Benzylamino-1-methylethyl)-4-methyl-
cyclohexane-1,2-diol 7b
Isolated compound: 0.38 g (51%); white crystals, mp: 138–
140 °C; ½a 2D0
ꢂ
= ꢀ26 (c 0.250, MeOH). 1H NMR (400 MHz, CDCl3) d
0.99 (3H, d, J = 7.4), 1.21 (3H, s), 1.28 (3H, s), 1.24–1.33 (1H, m),
1.45–1.67 (4H, m), 1.79–1.90 (1H, m), 1.98–2.08 (1H, m), 3.73
(2H, q, J = 11.8, 18.6 Hz), 4.21 (1H, dd, J = 6.0, 10.8 Hz), 7.22–7.37
(5H, m). 13C NMR (100 MHz, CDCl3) d 17.7, 19.8, 21.9, 25.0, 26.5,
27.1, 35.7, 46.4, 61.1, 67.8, 76.5, 127.4, 128.4, 128.8, 140.0. Anal.
Calcd for C17H27NO2: C, 73.61; H, 9.81; N, 5.05. Found: C, 73.47;
H, 10.03; N, 5.13.
4.4. General procedure for the hydrolysis of trichloroacetyl
protecting group
A solution of 5a or 5b (0.5 g, 1.5 mmol) in Et2O (10 mL) was stir-
red with 18% aqueous HCl solution (15 mL) at room temperature.
After 168 h, the aqueous and organic phases were separated and
the aqueous phase was washed with Et2O (2 ꢁ 50 mL) and then
evaporated to dryness. To the obtained crude product 10% KOH
solution was added (50 mL) and the mixture was extracted with
CH2Cl2 (3 ꢁ 50 mL). The organic layer was dried (Na2SO4) and
evaporated.
4.5.3. (1R,2R,4R)-1-[1-(3,5-Di-tert-butylbenzylamino)-1-methyl-
ethyl]-4-methylcyclohexane-1,2-diol 8a
Isolated compound: 0.28 g (27%); white crystals; mp: 122–
123 °C; ½a 2D0
ꢂ
= +15 (c 0.250, MeOH). 1H NMR (400 MHz, CDCl3) d
0.92 (3H, d, J = 6.2), 1.14 (2H, q, J = 12.0, 23.8 Hz), 1.27 (4H, s),
1.22 (3H, s), 1.32 (18H, s), 1.34–1.48 (2H, m), 1.69–1.80 (2H, m),
3.70 (2H, q, J = 11.3, 15.2 Hz), 4.00 (1H, dd, J = 4.7, 12.0 Hz), 7.10
(2H, d, J = 1.8 Hz), 7.33 (1H, t, J = 1.9 Hz). 13C NMR (100 MHz,
CDCl3) d 19.9, 21.8, 22.0, 29.9, 30.2, 30.6, 31.6, 35.0, 39.1, 47.0,
60.8, 72.2, 75.8, 121.5, 122.8, 139.0, 151.3. Anal. Calcd for
4.4.1. (1R,2R,4R)-1-(1-Amino-1-methylethyl)-4-methylcyclohex-
ane-1,2-diol 6a
Isolated compound: 0.24 g (85%); colourless oil; ½a D20
ꢂ
= +26 (c
d 0.92 (3H, d,
0.250, MeOH). 1H NMR (400 MHz, CDCl3)
J = 6.2 Hz), 1.18 (3H, s), 1.20 (3H, s), 1.15–1.28 (3H, m), 1.32–1.46
(2H, m), 1.66–1.75 (2H, m), 3.94 (1H, dd, J = 4.9, 11.4 Hz). 13C
NMR (100 MHz, CDCl3) d 22.1, 25.7, 28.5, 29.9, 30.3, 30.8, 39.0,
57.0, 72.4, 74.9. Anal. Calcd for C10H21NO2: C, 64.13; H, 11.30; N,
7.48. Found: C, 64.02; H, 11.51; N, 7.40.
C25H43NO2: C,77.07; H, 11.12; N, 3.60. Found: C, 77.14; H, 11.01;
N, 3.58.
4.5.4. (1S,2S,4R)-1-[1-(3,5-Di-tert-butylbenzylamino)-1-methyl-
ethyl]-4-methylcyclohexane-1,2-diol 8b
Isolated compound: 0.45 g (43%); white crystals; mp: 114–
4.4.2. (1S,2S,4R)-1-(1-Amino-1-methylethyl)-4-methylcyclohex-
ane-1,2-diol 6b
116 °C; ½a 2D0
ꢂ
= ꢀ20 (c 0.250, MeOH). 1H NMR (400 MHz, CDCl3) d
0.99 (3H, d, J = 7.4 Hz), 1.13 (3H, s), 1.30 (3H, s) 1.32 (18H, s),
1.24–1.34 (1H, m), 1.46–1.64 (4H, m), 1.80–1.91 (1H, m), 2.97–
1.09 (1H, m), 3.70 (2H, q, J = 11.6, 16.4 Hz), 4.23 (1H, dd, J = 6.3,
10.5 Hz), 7.10 (2H, d, J = 1.8 Hz), 7.33 (1H, t, J = 1.8 Hz). 13C NMR
(100 MHz, CDCl3) d 17.7, 19.7, 21.9, 25.0, 26.5, 27.2, 31.6, 35.0,
35.8, 47.1, 61.1, 67.7, 76.5, 121.5, 122.8, 138.9, 151.3. Anal. Calcd
for C25H43NO2: C,77.07; H, 11.12; N, 3.60. Found: C, 76.95; H,
11.31; N, 3.54.
Isolated compound: 0.23 g (83%); white crystals; mp: 72–75 °C;
½
a 2D0
ꢂ
= ꢀ36 (c 0.250, MeOH). 1H NMR (400 MHz, CDCl3) d 0.97 (3H,
d, J = 7.3 Hz), 1.18 (3H, s), 1.23 (3H, s), 1.24–1.30 (1H, m), 1.40–1.71
(4H, m), 1.79–1.90 (1H, m), 1.99–2.08 (1H, m), 4.16 (1H, dd, J = 5.2,
11.6 Hz). 13C NMR (100 MHz, CDCl3) d 17.7, 25.1, 25.7, 26.5, 27.3,
28.3, 35.7, 57.2, 67.9, 75.6. Anal. Calcd for C10H21NO2: C, 64.13;
H, 11.30; N, 7.48. Found: C, 64.29; H, 11.07; N, 7.46.
4.5. General procedure for the reductive alkylation of
aminodiols
4.6. General procedure for the ring closure of monobenzyl
substituted aminodiols
To
a
solution of primary aminodiols 6a and 6b (0.50 g,
To a solution of 7a or 7b (0.30 g, 1.6 mmol) in Et2O (6 mL), 35%
aqueous formaldehyde solution (5 mL) was added. The reaction
mixture was stirred for 1 h at room temperature, after which was
added alkaline with 10% cool aqueous KOH solution and extracted
with Et2O (3 ꢁ 20 mL). The combined organic layer was washed
with saturated NaCl solution (3 ꢁ 30 mL), then dried (Na2SO4), fil-
tered and evaporated to dryness. The crude product was purified
by column chromatography on silica gel (n-hexane/EtOAc = 9/1).
2.7 mmol) in dry ethanol (25 mL), was added the appropriate alde-
hyde (2.8 mmol) in one portion, and the solution was stirred at
room temperature for 1 h and then evaporated to dryness. The
residual product was dissolved in dry ethanol (25 mL) and stirred
for a further 1 h. Next NaBH4 (0.30 g, 7.9 mmol) was added in small
portions to the mixture under ice cooling. After refluxing for 48 h,
the mixture was evaporated to dryness and the residue was dis-